About This Product
Retatrutide Research Guide
Overview
Retatrutide represents the cutting edge of incretin research as a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This unique mechanism enables comprehensive metabolic pathway investigation impossible with single or dual agonists.
Triple Receptor Mechanism
- GLP-1 Receptor: Appetite regulation and insulin secretion
- GIP Receptor: Enhanced insulin sensitivity and lipid handling
- Glucagon Receptor: Increased energy expenditure and fat oxidation
Quality Standards
- Purity: >99% verified by HPLC and Mass Spectrometry
- Form: Lyophilized powder
- Storage: -20°C long-term
- Documentation: Full CoA included
For research purposes only. Not for human consumption.
Patrick O. — United Kingdom (verified owner) –
Three months on this protocol. Results are the best I’ve had from any GLP-1 compound. Quality is excellent.
Wei L. — Switzerland (verified owner) –
Came well packaged. Reconstituted with BW without any cloudiness — a good sign of purity.